Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus

NCT00299871 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
542
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi